Dexcom (DXCM) Notes Payables (2022 - 2025)
Dexcom (DXCM) reported Notes Payables of $1.2 billion for Q3 2025, little changed quarter-over-quarter from $1.2 billion in Q2 2025.
Dexcom (DXCM) Notes Payables (2022 - 2025) Analysis & Trends
Dexcom (DXCM) has 4 years of Notes Payables data on file, last reported at $1.2 billion in Q3 2025.
- Notes Payables for Q3 2025 came in at $1.2 billion, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was $1.2 billion (changed N/A YoY), and the FY2024 annual result was $1.2 billion, changed N/A from the prior year.
- Notes Payables was little changed at $1.2 billion in Q3 2025 per DXCM's latest filing, from $1.2 billion in the prior quarter.
- Over five years, Notes Payables peaked at $1.2 billion in Q3 2025 and troughed at $124.2 million in Q3 2023.
- A 4-year average of $908.3 million and a median of $989.1 million in 2023 frame the typical range for Notes Payables.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.21 Bn |
| Jun 30, 2025 | 1.21 Bn |
| Mar 31, 2025 | 1.21 Bn |
| Dec 31, 2024 | 1.20 Bn |
| Sep 30, 2023 | 124.20 Mn |
| Jun 30, 2023 | 773.80 Mn |
| Mar 31, 2023 | 773.20 Mn |
| Dec 31, 2022 | 772.60 Mn |